A study by a team of Chinese researchers highlights the potential of optical coherence tomography angiography (OCTA) in ...

Myopia prevalence is increasing, potentially affecting 5 billion people by 2050, necessitating global collaborative efforts.

ABI-110 has the potential to offer a durable and effective solution by addressing the root causes of wet AMD at the genetic ...

Researchers decoded zebrafish brainstem neuron networks guiding gaze, using advanced imaging techniques and a simplified ...

Differentiating hereditary from nonhereditary retinoblastoma is now possible overnight, improving early intervention ...

Special circumstances must be considered for plateau dwellers, such as Tibetans, mountaineers, and garrison officers, who are ...

The California Institute for Regenerative Medicine has funded Keck School of Medicine of USC translational research advancing ...

Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating ...

Melt Pharmaceuticals announced positive results from its Phase 3 study of MELT-300, a non-IV, non-opioid tablet for ...

Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...

SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...

Emmecell announced positive Phase 1 extension study results for EO2002, a nonsurgical cell therapy for corneal edema. The ...